logo

XBIO

Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)

XBIO fundamentals

Xenetic Biosciences (XBIO) released its earnings on Aug 12, 2025: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), missed estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 12, 2025
EPS
Q1,2020
Q2,2021
Q3,2021
Q1,2022
Q1,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-1.9-1.3-1.3-1.2-0.76-0.78-0.83-0.28-0.68-0.59
Forecast
-3.7-1.3-1.2-1.2-0.56-0.76-0.78-0.83-0.14-0.68-0.72-0.64
Surprise
+48.65%
0.00%
-8.33%
0.00%
0.00%
0.00%
0.00%
0.00%
-100.00%
0.00%
+18.06%
0.00%
Revenue
Q1,2020
Q2,2021
Q3,2021
Q1,2022
Q1,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
58.50K287.60K349.27K390.00K--670.00K510.82K726.40K614.24K650.00K590.00K--
Forecast
0290.00K200.00K390.00K610.00K670.00K510.00K540.00K750.00K650.00K670.00K600.00K
Surprise
0.00%
-0.83%
+74.63%
0.00%
0.00%
0.00%
+0.16%
+34.52%
-18.10%
0.00%
-11.94%
0.00%

Earnings Call